BrokerBank Securities, Inc.: Study Finds That Medical Marijuana May Help HIV and AIDS Patients and Prevent Transmission

NEW YORK, March 5, 2014 /PRNewswire/ -- Growlife Inc. (OTCQB: PHOT) Recent studies have shown that the use of marijuana in medicinal doses can reduce the symptoms and side effects of many illnesses, including joint pain and inflammation, several types of cancers and even Alzheimer's Disease. Glaucoma, eye problems and many other illnesses can all be helped by the use of medical marijuana. Now medical marijuana is providing new hope in the fight against the spread of HIV and AIDS. The medical community realizes that it is imperative that the immune system of patients with HIV and AIDS be supported and strengthened to give patients a better quality of life. In addition, the strengthening of the immune system with exercise, healthy eating and the proper medications can also help prevent HIV from progressing to the full AIDS virus. The typical treatments for patients with HIV and AIDS are dangerous pharmaceuticals that can pose life-threatening side effects for patients. However, new research has shown that there may be a healthy, natural alternative for these dangerous medications.

A ground-breaking new study has shown that THC, the major cannabinoid in marijuana, can effectively protect and support the immune system of HIV patients. This results in less viral load and inflammation of tissue. Patients exhibit less symptoms of the disease when utilizing the benefits of THC. The use of medical grade marijuana also slows or completely halts the progression of HIV to AIDS. The use of THC may also be able to reduce or even block the spread of HIV and AIDS. This is amazing news for everyone, including those dealing with HIV and AIDS, medical personnel and those at risk for acquiring these viruses.

Much work is still to be done in this area. However, an amazing study has recently been published, outlining these developments, to help educate the public on how the use of medical marijuana can help slow or stop the spread of the HIV and AIDS epidemic. A synopsis of this study is available, and can help answer your questions about how the treatment works and what still needs to be done to make this treatment accessible to all patients. The following link will allow you to view this report at no cost:

http://bit.ly/PHOT-AnalystReport

Copy and paste may be required

FORWARD-LOOKING DISCLAIMER

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is written and authored by Marc Bonacci, Chief Analyst. An outsourced research services provider represented by Marc Bonacci, Chief Analyst, provided Small Cap Street, LLC this article or report. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. Small Cap Street, LLC and BrokerBank Securities, Inc. are not entitled to veto, interfere or alter the articles, documents or report once created and reviewed by the outsourced research provider represented by Marc Bonacci, Chief Analyst.

If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected]. For any urgent concerns or inquiries, please contact us at [email protected].

NO WARRANTY OR LIABILITY ASSUMED

PHOT has not compensated Small Cap Street, LLC, BrokerBank Securities, Inc, or Marc Bonacci, Chief Analyst for the creation or dissemination of this report. Small Cap Street, LLC and BrokerBank Securities, Inc, is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Small Cap Street, LLC and BrokerBank Securities, Inc. whatsoever for any direct, indirect or consequential loss arising from the use of this document. Small Cap Street, LLC and BrokerBank Securities, Inc. expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Small Cap Street, LLC and BrokerBank Securities, Inc. do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

Small Cap Street, LLC is the party responsible for hosting the full analyst report on smallcapstreet.com. BrokerBank Securities in the party responsible for issuing the press release and Marc Bonacci, Chief Analyst, is the author of research report.  Information in this release is fact checked and produced on a best efforts basis by Marc Bonacci, Chief Analyst.

BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.

SOURCE BrokerBank Securities, Inc.